This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wyrick, P. B. Articles by Malamud, D. Search for Related Content PubMed PubMed Citation Articles by Wyrick, P. B. Articles by Malamud, D.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, 06 1997, 1335-1344, Vol 41, No. 6
Copyright © 1997 by the American Society for Microbiology. All rights reserved.

The microbicidal agent C31G inhibits Chlamydia trachomatis infectivity in vitro

PB Wyrick, ST Knight, DG Gerbig Jr, JE Raulston, CH Davis, TR Paul and D Malamud
Department of Microbiology and Immunology, University of North Carolina- Chapel Hill School of Medicine, North Carolina, 27599-7290, USA. pbwyrick@med.unc.edu

Safe and effective vaginal microbicidal compounds are being sought to offer women an independent method for protection against transmission of sexually acquired pathogens. The purpose of this study was to examine the efficacy of two formulations of one such compound, C31G, against Chlamydia trachomatis serovar E alone, its host epithelial cell (HEC-1B) alone, and against chlamydiae-infected HEC-1B cells. Preexposure of isolated, purified infectious chlamydial elementary bodies (EB) to C31G, at pHs 7.2 and 5.7, for 1 h at 4 degrees C resulted in reduced infectivity of EB for HEC-1B cells. Examination of the C31G-exposed 35S-EB on sodium dodecyl sulfate-polyacrylamide gel electrophoresis autoradiographs and by Western blotting revealed a C31G concentration-dependent and pH-dependent destabilization of the chlamydial envelope, resulting in the release of chlamydial lipopolysaccharide and proteins. Interestingly, when the host human genital columnar epithelial cells were infected with chlamydiae and then exposed to dilute concentrations of C31G which did not alter epithelial cell viability, chlamydial infectivity was also markedly reduced. C31G gained access to the developing chlamydial inclusion causing damage to or destruction of metabolically active reticulate bodies as well as apparent alteration of the inclusion membrane, which resulted in premature escape of chlamydial antigen to the infected epithelial surface. These studies show that the broad-spectrum antiviral and antibacterial microbicide C31G also has antichlamydial activity.

This article has been cited by other articles:

• Yamazaki, T., Kishimoto, T., Shiga, S., Sato, K., Hagiwara, T., Inoue, M., Sasaki, N., Ouchi, K., Hara, Y. (2005). Biosynthesized Tea Polyphenols Inactivate Chlamydia trachomatis In Vitro. Antimicrob. Agents Chemother. 49: 2501-2503 [Abstract] [Full Text]  
• Jong, A. Y., Stins, M. F., Huang, S.-H., Chen, S. H. M., Kim, K. S. (2001). Traversal of Candida albicans across Human Blood-Brain Barrier In Vitro. Infect. Immun. 69: 4536-4544 [Abstract] [Full Text]  
• Birnie, C. R., Malamud, D., Schnaare, R. L. (2000). Antimicrobial Evaluation of N-Alkyl Betaines and N-Alkyl-N,N-Dimethylamine Oxides with Variations in Chain Length. Antimicrob. Agents Chemother. 44: 2514-2517 [Abstract] [Full Text]  
• Raulston, J. E., Paul, T. R., Knight, S. T., Wyrick, P. B. (1998). Localization of Chlamydia trachomatis Heat Shock Proteins 60 and 70 during Infection of a Human Endometrial Epithelial Cell Line In Vitro. Infect. Immun. 66: 2323-2329 [Abstract] [Full Text]